EDAP Edap Tms S.a.
Healthcare$4.31+0.23%ClosedMarket Cap: $161.5M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
15.96
P/S
2.24
EV/EBITDA
-6.35
DCF Value
$-45.31
FCF Yield
-12.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
43.4%
Operating Margin
-34.6%
Net Margin
-41.7%
ROE
-148.9%
ROA
-41.7%
ROIC
-72.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $17.9M | 45.7% | $-7.4M | $-9.1M | $— | — |
| Q4 null | $21.9M | 42.6% | $-6.0M | $-9.4M | $— | — |
| FY null | $70.7M | 42.5% | $-25.2M | $-29.3M | $— | — |
| Q3 null | $16.2M | 43.0% | $-5.8M | $-5.9M | $— | — |
| Q2 null | $16.0M | 42.5% | $-5.8M | $-5.6M | $— | — |
| Q1 null | $13.6M | 42.0% | $-6.0M | $-7.1M | $— | — |
| Q4 null | $20.3M | 44.8% | $-3.7M | $-1.9M | $— | — |
| FY null | $64.1M | 41.4% | $-20.5M | $-19.0M | $— | — |
| Q3 null | $13.1M | 39.4% | $-5.8M | $-6.4M | $— | — |
| Q2 null | $15.8M | 37.5% | $-6.1M | $-6.1M | $— | — |
| Q1 null | $14.9M | 42.8% | $-4.8M | $-4.5M | $— | — |
| Q4 2023 | $19.6M | 43.7% | $-3.5M | $-5.0M | $-0.14 | — |